Objectives of Programme's Learning Outcomes

Learning Outcomes of UE

Chemotherapy, hormone therapy, targeted therapy and immunotherapy. The course will be teached in english.
 

UE Content: description and pedagogical relevance

This course will develop the systemic treatment of cancer including chemotherapy, hormone therapy, targeted therapies (against signaling pathways and mutations), and immunotherapy. Cancer chemotherapy uses drugs that interfere with cell growth leading to cell death (cytotoxic drugs) or stopping cell proliferation (cytostatic drugs). This course will also discuss the importance of multidrug therapy. In the context of integrative oncology, the coordination of care between the pharmacist, the doctor and the hospital is important. The efficacy of anticancer treatments and the associated adverse effects will be discussed, in particular concerning the dermatological toxicity of oncological treatments. Finally, the role of pharmacists in supportive care will be presented.
 

Prior Experience

Not applicable